Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
17.76
-0.14 (-0.78%)
Feb 13, 2026, 4:00 PM EST - Market closed
Aktis Oncology Market Cap
Aktis Oncology has a market cap or net worth of $932.8 million as of February 13, 2026.
Market Cap
932.80M
Enterprise Value
698.44M
1-Year Change
n/a
Ranking
Category
Stock Price
17.76
Market Cap Chart
Since the IPO on January 9, 2026, Aktis Oncology's market cap has decreased from $945.40M to $932.80M, a decrease of -1.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 932.80M | -0.78% |
| Feb 12, 2026 | 940.15M | -0.89% |
| Feb 11, 2026 | 948.55M | 1.46% |
| Feb 10, 2026 | 934.90M | -6.32% |
| Feb 9, 2026 | 997.92M | 0.11% |
| Feb 6, 2026 | 996.87M | -3.01% |
| Feb 5, 2026 | 1.03B | -1.76% |
| Feb 4, 2026 | 1.05B | -4.69% |
| Feb 3, 2026 | 1.10B | -4.91% |
| Feb 2, 2026 | 1.15B | 8.54% |
| Jan 30, 2026 | 1.06B | 3.11% |
| Jan 29, 2026 | 1.03B | -4.20% |
| Jan 28, 2026 | 1.08B | -3.39% |
| Jan 27, 2026 | 1.11B | -1.85% |
| Jan 26, 2026 | 1.14B | -0.14% |
| Jan 23, 2026 | 1.14B | -3.35% |
| Jan 22, 2026 | 1.18B | 9.80% |
| Jan 21, 2026 | 1.07B | 8.68% |
| Jan 20, 2026 | 985.84M | -4.96% |
| Jan 16, 2026 | 1.04B | -3.94% |
| Jan 15, 2026 | 1.08B | -1.20% |
| Jan 14, 2026 | 1.09B | -2.53% |
| Jan 13, 2026 | 1.12B | -1.84% |
| Jan 12, 2026 | 1.14B | 20.83% |
| Jan 9, 2026 | 945.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 965.15M |
| Phathom Pharmaceuticals | 941.10M |
| UroGen Pharma | 940.86M |
| SpyGlass Pharma | 940.22M |
| AbCellera Biologics | 927.94M |
| ArriVent BioPharma | 927.18M |
| GH Research | 911.83M |
| Fortrea Holdings | 904.60M |